Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-038804

Chief Financial Officer bought 1,500 shares at $69.95 ($104,925)

From the SEC's structured data for this filing

Trades in this filing

Vu Quan Anh · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-26 Purchase : show line 1 in the form +1,500 $69.95 $104,925 1,500 D
Open-market purchases · 1,500 sh · avg $69.95 · $104,925
Loading xslF345X05/rdgdoc.xml…